摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2'S,3'S)-(7-O-benzyl-6-O-chloroacetyl-3,4-O-(2',3'-dimethoxybutane-2',3'-diyl)-L-glycero-α-D-manno-heptopyranosyl)-(1->3)-[(2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl)-(1->4)]-7-O-acetyl-1,6-anhydro-2-O-benzyl-L-glycero-β-D-manno-heptopyranose | 1023637-07-1

中文名称
——
中文别名
——
英文名称
(2'S,3'S)-(7-O-benzyl-6-O-chloroacetyl-3,4-O-(2',3'-dimethoxybutane-2',3'-diyl)-L-glycero-α-D-manno-heptopyranosyl)-(1->3)-[(2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl)-(1->4)]-7-O-acetyl-1,6-anhydro-2-O-benzyl-L-glycero-β-D-manno-heptopyranose
英文别名
(2'S,3'S)-7-O-benzyl-6-O-chloroacetyl-3,4-O-(2',3'-dimethoxybutane-2',3'-diyl)-L-glycero-α-D-manno-heptopyranosyl-(1->3)-[2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl-(1->4)]-7-O-acetyl-1,6-anhydro-2-O-benzyl-L-glycero-α-D-manno-heptopyranose;[(2R,3R,4S,5R,6S)-6-[[(1R,2R,3S,4S,5R,7S)-3-[[(2S,3S,4aR,5R,7R,8S,8aR)-5-[(1S)-1-(2-chloroacetyl)oxy-2-phenylmethoxyethyl]-8-hydroxy-2,3-dimethoxy-2,3-dimethyl-5,7,8,8a-tetrahydro-4aH-pyrano[3,4-b][1,4]dioxin-7-yl]oxy]-7-(acetyloxymethyl)-4-phenylmethoxy-6,8-dioxabicyclo[3.2.1]octan-2-yl]oxy]-3,4,5-tribenzoyloxyoxan-2-yl]methyl benzoate
(2'S,3'S)-(7-O-benzyl-6-O-chloroacetyl-3,4-O-(2',3'-dimethoxybutane-2',3'-diyl)-L-glycero-α-D-manno-heptopyranosyl)-(1->3)-[(2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl)-(1->4)]-7-O-acetyl-1,6-anhydro-2-O-benzyl-L-glycero-β-D-manno-heptopyranose化学式
CAS
1023637-07-1
化学式
C72H75ClO25
mdl
——
分子量
1375.83
InChiKey
VJQPVYWNCMMOGZ-HONMOIOQSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    8.3
  • 重原子数:
    98
  • 可旋转键数:
    33
  • 环数:
    11.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    289
  • 氢给体数:
    1
  • 氢受体数:
    25

反应信息

  • 作为反应物:
    描述:
    (2'S,3'S)-(7-O-benzyl-6-O-chloroacetyl-3,4-O-(2',3'-dimethoxybutane-2',3'-diyl)-L-glycero-α-D-manno-heptopyranosyl)-(1->3)-[(2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl)-(1->4)]-7-O-acetyl-1,6-anhydro-2-O-benzyl-L-glycero-β-D-manno-heptopyranose 、 ethyl 2,3,4,6,7-penta-O-benzoyl-1-thio-L-glycero-α-D-manno-heptopyranoside 在 N-碘代丁二酰亚胺silver trifluoromethanesulfonate 作用下, 以 二氯甲烷 为溶剂, 反应 1.0h, 以86%的产率得到(2'S,3'S)-(2,3,4,6,7-penta-O-benzoyl-L-glycero-α-D-manno-heptopyranosyl)-(1->2)-(7-O-benzyl-6-O-chloroacetyl-3,4-O-(2',3'-dimethoxybutane-2',3'-diyl)-L-glycero-α-D-manno-heptopyranosyl)-(1->3)-[(2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl)-(1->4)]-7-O-acetyl-1,6-anhydro-2-O-benzyl-L-glycero-β-D-manno-heptopyranose
    参考文献:
    名称:
    Synthesis of a common tetrasaccharide motif of Haemophilus influenzae LPS inner core structures
    摘要:
    一种保守的四糖结构,L-glycero-α-D-manno-heptopyranosyl-(1→2)-(6-O-氨乙基膦酸-L-glycero-α-D-manno-heptopyranosyl)-(1→3)-[β-D-glucopyranosyl-(1→4)]-L-glycero-α-D-manno-heptopyranose,已从流感嗜血杆菌的LPS内核中合成为其乙基氨基糖苷,以便于后续的连接。从先前合成的适当保护的三糖中间体开始,引入了第三个七碳糖,随后通过硫糖苷供体化学引入了连接体。磷酸乙醇胺是通过使用Boc保护的磷酸酰胺化合物形成的。最后去保护并与生物素连接,得到的结合物将用于研究针对天然LPS结构的单克隆抗体的特异性。
    DOI:
    10.1039/b717564g
  • 作为产物:
    描述:
    2,3-二氯-5,6-二氰基-1,4-苯醌 作用下, 以 二氯甲烷 为溶剂, 反应 4.0h, 以76%的产率得到(2'S,3'S)-(7-O-benzyl-6-O-chloroacetyl-3,4-O-(2',3'-dimethoxybutane-2',3'-diyl)-L-glycero-α-D-manno-heptopyranosyl)-(1->3)-[(2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl)-(1->4)]-7-O-acetyl-1,6-anhydro-2-O-benzyl-L-glycero-β-D-manno-heptopyranose
    参考文献:
    名称:
    Synthesis of a common tetrasaccharide motif of Haemophilus influenzae LPS inner core structures
    摘要:
    一种保守的四糖结构,L-glycero-α-D-manno-heptopyranosyl-(1→2)-(6-O-氨乙基膦酸-L-glycero-α-D-manno-heptopyranosyl)-(1→3)-[β-D-glucopyranosyl-(1→4)]-L-glycero-α-D-manno-heptopyranose,已从流感嗜血杆菌的LPS内核中合成为其乙基氨基糖苷,以便于后续的连接。从先前合成的适当保护的三糖中间体开始,引入了第三个七碳糖,随后通过硫糖苷供体化学引入了连接体。磷酸乙醇胺是通过使用Boc保护的磷酸酰胺化合物形成的。最后去保护并与生物素连接,得到的结合物将用于研究针对天然LPS结构的单克隆抗体的特异性。
    DOI:
    10.1039/b717564g
点击查看最新优质反应信息

文献信息

  • Synthesis of phosphorylated Neisseria meningitidis inner core lipopolysaccharide structures
    作者:Johan D.M. Olsson、Stefan Oscarson
    DOI:10.1016/j.tetasy.2009.02.017
    日期:2009.5
    A phosphoethanolamine-substituted tetrasaccharide structure, 2-aminoethyl 2-acetamido-2-deoxy-alpha-D-glucopyranosyl-(1 -> 2)-6-O-[2-(tert-butyloxycarbonylaminoethyl)-phophono]-L-glycero-alpha-D-manno-heptopyranosyl-(1 -> 3)-[beta-D-glucopyranosyl-(1 -> 4)]-L-glycero-alpha-D-manno-heptopyranoside,corresponding to the non-reducing part of the conserved part of Neisseria meningitidis lipopolysaccharides has been synthesized. Orthogonal protection of the phosphoethanolamino group in combination with the presence of a free amino-containing anomeric spacer allows conjugation to proteins to construct conjugate vaccine candidates. The tetrasaccharide is built up using a linear strategy, where the introduction Of the terminal alpha-GlcNAc moiety is performed using a 2-azido-thioglucoside as a donor and NIS/AgOTf as a promoter. The synthetic pathway includes tetrasaccharide intermediates appropriately designed to permit other phosphorylation patterns as well as elongation at the reducing end. (C) 2009 Elsevier Ltd. All rights reserved.
  • Synthesis of a common tetrasaccharide motif of Haemophilus influenzae LPS inner core structures
    作者:Karin Mannerstedt、Eva Segerstedt、Johan Olsson、Stefan Oscarson
    DOI:10.1039/b717564g
    日期:——
    A conserved tetrasaccharide structure, L-glycero-α-D-manno-heptopyranosyl-(1→2)-(6-O-aminoethylphosphono-L-glycero-α-D-manno-heptopyranosyl)-(1→3)-[β-D-glucopyranosyl-(1→4)]-L-glycero-α-D-manno-heptopyranose, from the LPS inner core of Haemophilus influenzae has been synthesised as its ethylamino glycosides to allow later conjugations. Starting from a previously synthesised suitably protected trisaccharide intermediate, the third heptose and subsequently the spacer were introduced using thioglycoside donor chemistry. The phosphoethanolamine was formed employing a Boc-protected phosphoamidite. Final deprotection and conjugation to biotin gave conjugates that will be used to study the specificity of MAbs raised against native LPS structures.
    一种保守的四糖结构,L-glycero-α-D-manno-heptopyranosyl-(1→2)-(6-O-氨乙基膦酸-L-glycero-α-D-manno-heptopyranosyl)-(1→3)-[β-D-glucopyranosyl-(1→4)]-L-glycero-α-D-manno-heptopyranose,已从流感嗜血杆菌的LPS内核中合成为其乙基氨基糖苷,以便于后续的连接。从先前合成的适当保护的三糖中间体开始,引入了第三个七碳糖,随后通过硫糖苷供体化学引入了连接体。磷酸乙醇胺是通过使用Boc保护的磷酸酰胺化合物形成的。最后去保护并与生物素连接,得到的结合物将用于研究针对天然LPS结构的单克隆抗体的特异性。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物